Company
Headquarters: Dublin, Ireland
Founded: 1948
Employees: 9,000
CEO: Mr. Brendan Patrick McAtamney
£2.72 Billion
GBP as of Aug. 1, 2021
US$3.77 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is headquartered in Dublin, the Republic of Ireland. As of August 16, 2021, UDG Healthcare plc was taken private.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
UDG Healthcare plc has the following listings and related stock indices.
Stock: LSE: UDG wb_incandescent
Stock: FSX: UN6A wb_incandescent
Peter Gray, Chairman Brendan Mc Atamney, CEO
Revenue: €1,279.2 million (2020)
Operating income: €130.9 million (2020)
Net income: €92.8 million (2020)